Terpstra O T, Ausema B, Bruining H A, Laméris J S, Reuvers C B, Schalm S W, van Urk H, Wilson J H
Department of Surgery, University Hospital 'Dijkzigt', Erasmus University, Rotterdam, The Netherlands.
Br J Surg. 1987 Sep;74(9):787-90. doi: 10.1002/bjs.1800740911.
Survival, encephalopathy and shunt patency were studied in 64 consecutive patients who underwent mesocaval shunting with a wide-calibre Dacron prosthesis. Half of the patients were operated as emergency cases. Operative blood loss in patients who had emergency procedures was significantly higher than during elective operations. Overall, 30-day mortality was 27 per cent. Survival was 61 per cent after 1 year and 39 per cent after 5 years. Serious encephalopathy requiring hospital admission occurred in 5 patients (11 per cent of patients surviving more than 1 month). Shunt patency was assessed by scintisplenoportography and ultrasonography. Cumulative shunt occlusion rate was 16 per cent after 1 year, 33 per cent after 5 years and 52 per cent after 8 years of follow-up. Out of 17 patients with an occluded shunt, 9 had persistent or recurrent bleeding, while 3 patients had recurrent bleeding despite a patent shunt. We conclude that the mesocaval Dacron interposition shunt should not be recommended as the procedure of first choice for portosystemic shunting.
对64例连续接受使用大口径涤纶人工血管的肠系膜上静脉-腔静脉分流术的患者进行了生存情况、脑病情况及分流管通畅情况的研究。一半患者为急诊手术。接受急诊手术的患者术中失血量显著高于择期手术患者。总体而言,30天死亡率为27%。1年后生存率为61%,5年后为39%。5例患者(存活超过1个月患者的11%)出现需要住院治疗的严重脑病。通过闪烁脾门静脉造影术和超声检查评估分流管通畅情况。随访1年后分流管累积闭塞率为16%,5年后为33%,8年后为52%。在17例分流管闭塞的患者中,9例有持续性或复发性出血,而3例分流管通畅的患者也有复发性出血。我们得出结论,肠系膜上静脉-腔静脉涤纶搭桥分流术不应被推荐作为门体分流术的首选术式。